GGrantIndex
Sort

40,608 grants matching prostate cancer

BKV and JCV vaccine development

$772,907
Christopher Buck · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA

Tumor stem cells and metastatic outcomes in mouse models of prostate cancer

$772,849
Kathleen Kelly · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA

Synthesis of Antitumor Natural Products

$772,528
Samuel J Danishefsky · Sloan-Kettering Inst Can Research · R37 · FY2009 · CA

(PQ3) Identifying Novel Pharmacologic Risk factors for Common Non-AIDS Defining Cancers in Individuals with Well-controlled HIV Infection

$772,521
Elizabeth Chiao · Baylor College Of Medicine · R01 · FY2017 · CA

(PQ3) Identifying Novel Pharmacologic Risk factors for Common Non-AIDS Defining Cancers in Individuals with Well-controlled HIV Infection

$772,521
Elizabeth Chiao · Baylor College Of Medicine · R01 · FY2016 · CA

INTEGRATED GENOMIC BIOMARKERS TO IDENTIFY AGGRESSIVE DISEASE IN AFRICAN AMERICANS WITH PROSTATE CANCER

$772,234
Henry Ford Health System · · FY2015 · Department of Defense

Identification of Single Nucleotide Polymorphisms in Cancer-Related Genes

$772,224
Michael Dean · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA

Beaumont Community Clinical Oncology Program

$771,835
John M Robertson · William Beaumont Hospital Research Inst · U10 · FY2012 · CA

Synthesis of Antitumor Natural Products

$771,834
Samuel J Danishefsky · Sloan-Kettering Inst Can Research · R37 · FY2011 · CA

BKV and JCV vaccine development

$771,566
Christopher Buck · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA

Developmental Funds

$771,514
Howard H Bailey · University Of Wisconsin-Madison · P30 · FY2022 · CA

Uncovering causal protein markers to improve prostate cancer etiology understanding and risk prediction in Africans and Europeans

$770,796
Lang Wu · University Of Hawaii At Manoa · R01 · FY2022 · CA

ARKANSAS SPECIAL POPULATIONS ACCESS NETWORK (A-SPAN)

$770,751
University Of Arkansas Med Scis Ltl Rock · U01 · FY2003 · CA

NATIONAL COMPREHENSIVE CANCER CONTROL PROGRAM, PROSTATE CANCER AND COLORECTAL

$770,693
Victor M Yano · Republic Of Palau Ministry Of Health · U58 · FY2007 · DP

Consequences of retrotransposition on genome integrity

$770,690
Kathleen H Burns · Dana-Farber Cancer Inst · R01 · FY2023 · CA

Maryland Prostate Cancer Case-Control Study

$770,424
Stefan Ambs · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA

THERAPEUTIC TARGETING OF NEUROENDOCRINE PROSTATE CANCER

$770,346
The University Of British Columbia · · FY2018 · Department of the Army

Genetic Epidemiology of Cancer

$770,313
Joan E. Bailey-Wilson · National Human Genome Research Institute · ZIA · FY2010 · HG

Identification of epigenetic drivers of castration-resistant prostate cancer

$770,014
David Takeda · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA

Mechanism of epigenetic activation during disease progression

$770,014
David Takeda · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA

Prioritizing rare variants associated with cancer using non-coding annotation

$769,592
Mark Bender Gerstein · Yale University · R01 · FY2018 · HG

Carolina Community Network Center to Reduce Cancer Health Disparities (CCN II)

$769,502
Paul A. Godley · Univ Of North Carolina Chapel Hill · U54 · FY2011 · CA

Risk prediction methods

$769,379
Mitchell H Gail · Division Of Cancer Epidemiology And Genetics · ZIA · FY2015 · CA

PATTERNS OF CARE STUDY IN RADIATION ONCOLOGY

$769,331
American College Of Radiology · R01 · FY2000 · CA

Chromosome Instability Drives Metal-Induced Lung Cancer

$769,278
John Pierce Wise · University Of Louisville · R35 · FY2021 · ES